Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Report (No Activity)

REMEDY PARTNERS

via MEHLMAN CONSULTING, INC.

1st Quarter (Jan 1 - Mar 31) · 2019Posted Apr 18, 2019Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: REMEDY PARTNERS
Description: Healthcare Technology
Location: Connecticut · United States of America

Registrant

Firm: MEHLMAN CONSULTING, INC.
Description: Government Affairs Consulting Services
Location: WASHINGTON, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

REMEDY PARTNERS — Lobbying — Receipts Report